Jun 10, 2020
Memory Health Formulation Featured in New Study on Improving Mild Cognitive Impairment (MCI)
May 19, 2020
Results of GERAS-US Study Demonstrate Societal Cost Burden for Patients and Caregivers During Early Stages of Alzheimer's Disease
Mar 24, 2020
Okayama University Research: Novel Blood-based Markers to Detect Alzheimer's Disease
Feb 11, 2020
T3D Therapeutics Begins Enrollment in the PIONEER Phase 2 Clinical Trial of T3D-959 in Patients with Mild to Moderate Alzheimer's Disease
Dec 05, 2019
BioArctic's Partner Eisai Presents Data from the Ongoing BAN2401 Phase 2b Extension Study in Early Alzheimer's Disease
Sep 11, 2019
AgeneBio Announces Additional Funding to Advance Novel GABA-A Therapeutic Program to Address Alzheimer's and Other CNS Conditions
Jul 16, 2019
NetNoggin® releases results from "Utilization of Technology in Alzheimer's Disease" research study
Jul 15, 2019
Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias
Jun 11, 2019
Neurotrack Raises $21M in Series C Funding
May 30, 2019
Alzheimer's Drug Discovery Foundation Announces the First Award Recipients of its Diagnostics Accelerator Program
May 10, 2019
Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer's Disease
Apr 08, 2019
Life Molecular Imaging Applauds the Publication of the IDEAS Study Aim I Results
Mar 29, 2019
Data Safety Monitoring Board Recommends Continuation Of Phase III Clinical Studies Of BACE Inhibitor Elenbecestat In Early Alzheimer's Disease
Mar 22, 2019
Initiation Of Phase III Clinical Trial Of BAN2401 In Early Alzheimer's Disease
Jan 28, 2019
Alzheimer's Association Funds Two-year Extension Of The SPRINT MIND Study
Jan 07, 2019
Winterlight Labs, Inc. Enters Collaboration with Johnson & Johnson Innovation to Develop a Digital Biomarker for Diagnosis of Early Stage Alzheimer's Disease
Dec 04, 2018
Alkahest Doses First Subject in Phase 2 Clinical Trial of GRF6021 in Patients with Parkinson's Disease and Cognitive Impairment
Nov 08, 2018
NetNoggin® announces the release of NetNog: #genesis® Alzheimer's Disease (including MCI)
Oct 25, 2018
BioArctic Announces Additional BAN2401 Phase 2b Study Results in Early Alzheimer's Disease Presented by Eisai at the 2018 CTAD Conference
Oct 09, 2018
AgeneBio Announces Two NIH Grant Awards to Advance its Therapeutic Pipeline to Combat Progression of Alzheimer's Disease